Skip to main content

Thermo Fisher Scientific Inc(TMO-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low522.95
Day High538.41
Open:529.87
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Rothschild & Co Redburn Sticks to Their Buy Rating for Thermo Fisher (TMO)
AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost Advantages
Erste Group Remains a Hold on Thermo Fisher (TMO)
Analysts’ Top Healthcare Picks: Thermo Fisher (TMO), Eli Lilly & Co (LLY)
Thermo Fisher Completes Strategic Acquisition of Clario Holdings
Thermo Fisher Issues $3.8 Billion Notes for Acquisition
William Blair Reaffirms Their Buy Rating on Thermo Fisher (TMO)
C WorldWide Group Loads Up 45,000 MercadoLibre Shares Worth $94 Million
Analysts Are Bullish on These Healthcare Stocks: Thermo Fisher (TMO), Tenet Healthcare (THC)
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Intuitive Surgical (ISRG) and Thermo Fisher (TMO)
Thermo Fisher Scientific Earnings Call Highlights Steady Growth
Morgan Stanley Sticks to Its Buy Rating for Thermo Fisher (TMO)
Analysts Offer Insights on Healthcare Companies: Thermo Fisher (TMO), Phibro Animal Health (PAHC) and Unicycive Therapeutics (UNCY)
Analysts Offer Insights on Healthcare Companies: Thermo Fisher (TMO) and Mesoblast Limited (OtherMEOBF)
Analysts Offer Insights on Healthcare Companies: Hinge Health, Inc. Class A (HNGE), Nurix Therapeutics (NRIX) and Thermo Fisher (TMO)

Profile

Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics.